Spectrum Pharmaceuticals to divest seven oncology drugs in $300m deal with Acrotech Biopharma

In a major strategic move, Spectrum Pharmaceuticals, a prominent US-based biopharma company, has entered into a deal with Acrotech Biopharma, a subsidiary of Aurobindo Pharma ... Read More